Cargando…
La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2()
The accumulation of senescent cells in tissues is a key process of aging and age-related diseases, including lung diseases such as chronic obstructive pulmonary disease, lung fibrosis, or cancer. In recent years, the spectrum of respiratory diseases associated with cellular senescence has been broad...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
l'Académie nationale de médecine. Published by Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812359/ https://www.ncbi.nlm.nih.gov/pubmed/36624738 http://dx.doi.org/10.1016/j.banm.2022.11.011 |
_version_ | 1784863709828481024 |
---|---|
author | Adnot, S. Bernard, D. Lipskaia, L. Trottein, F. |
author_facet | Adnot, S. Bernard, D. Lipskaia, L. Trottein, F. |
author_sort | Adnot, S. |
collection | PubMed |
description | The accumulation of senescent cells in tissues is a key process of aging and age-related diseases, including lung diseases such as chronic obstructive pulmonary disease, lung fibrosis, or cancer. In recent years, the spectrum of respiratory diseases associated with cellular senescence has been broadened, in particular acute viral pulmonary infections, foremost among which is coronavirus disease 2019 (COVID19), which is particularly severe in the elderly or in subjects with comorbidities. Influenza virus infection, which strikes more severely at the extreme ages of life, is also associated with severe pulmonary senescence. Cellular senescence potentially represents an original target for attacking these diseases, although its specific mechanisms remain largely misunderstood. New anti-senescent therapeutic approaches are thus proposed during severe viral pulmonary infections, with the aim of preventing acute effects and/or, in the longer term, pulmonary sequelae. |
format | Online Article Text |
id | pubmed-9812359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | l'Académie nationale de médecine. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98123592023-01-05 La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2() Adnot, S. Bernard, D. Lipskaia, L. Trottein, F. Bull Acad Natl Med Revue Générale The accumulation of senescent cells in tissues is a key process of aging and age-related diseases, including lung diseases such as chronic obstructive pulmonary disease, lung fibrosis, or cancer. In recent years, the spectrum of respiratory diseases associated with cellular senescence has been broadened, in particular acute viral pulmonary infections, foremost among which is coronavirus disease 2019 (COVID19), which is particularly severe in the elderly or in subjects with comorbidities. Influenza virus infection, which strikes more severely at the extreme ages of life, is also associated with severe pulmonary senescence. Cellular senescence potentially represents an original target for attacking these diseases, although its specific mechanisms remain largely misunderstood. New anti-senescent therapeutic approaches are thus proposed during severe viral pulmonary infections, with the aim of preventing acute effects and/or, in the longer term, pulmonary sequelae. l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2023-02 2023-01-04 /pmc/articles/PMC9812359/ /pubmed/36624738 http://dx.doi.org/10.1016/j.banm.2022.11.011 Text en © 2022 l'Académie nationale de médecine. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Revue Générale Adnot, S. Bernard, D. Lipskaia, L. Trottein, F. La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2() |
title | La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2() |
title_full | La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2() |
title_fullStr | La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2() |
title_full_unstemmed | La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2() |
title_short | La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2() |
title_sort | la sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au sars-cov-2() |
topic | Revue Générale |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812359/ https://www.ncbi.nlm.nih.gov/pubmed/36624738 http://dx.doi.org/10.1016/j.banm.2022.11.011 |
work_keys_str_mv | AT adnots lasenescencecellulairenouvellecibledesinfectionsviralesrespiratoiresduvirusinfluenzaausarscov2 AT bernardd lasenescencecellulairenouvellecibledesinfectionsviralesrespiratoiresduvirusinfluenzaausarscov2 AT lipskaial lasenescencecellulairenouvellecibledesinfectionsviralesrespiratoiresduvirusinfluenzaausarscov2 AT trotteinf lasenescencecellulairenouvellecibledesinfectionsviralesrespiratoiresduvirusinfluenzaausarscov2 |